U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
198481198481A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIVCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001049
198482198482Comparison of Anti HIV Drugs Used Alone or in Combination With Cytosine Arabinoside to Treat Progressive Multifocal Leukoencephalopathy (PML) in HIV-Infected PatientsCompletedNo Results AvailableHIV Infections|Leukoencephalopathy, Progressive MultifocalDrug: Filgrastim|Drug: Cytarabine|Drug: Zidovudine|Drug: Zalcitabine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001048
198483198483Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDSCompletedNo Results AvailableMycobacterium Avium-intracellulare Infection|HIV InfectionsDrug: Ethambutol hydrochloride|Drug: Clarithromycin|Drug: Clofazimine|Drug: Rifabutinhttps://ClinicalTrials.gov/show/NCT00001047
198484198484Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)WithdrawnNo Results AvailableHIV Infections|Pregnancy|HIV SeronegativityBiological: MF59|Biological: rgp120/HIV-1 SF-2https://ClinicalTrials.gov/show/NCT00001046
198485198485Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the DiseaseCompletedNo Results AvailableHIV InfectionsDrug: Nevirapine|Drug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001045
198486198486A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.CompletedNo Results AvailableHIV InfectionsBiological: Aluminum hydroxide|Biological: QS-21|Biological: rgp120/HIV-1MNhttps://ClinicalTrials.gov/show/NCT00001044
198487198487A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination SchedulesCompletedNo Results AvailableHIV Infections|HIV SeronegativityBiological: gp160 Vaccine (Immuno-AG)https://ClinicalTrials.gov/show/NCT00001043
198488198488A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected IndividualsCompletedNo Results AvailableHIV InfectionsBiological: Aluminum hydroxide|Biological: Lipid A, Monophosphoryl|Biological: Lipid A, Liposome-encapsulated monophosphoryl|Biological: Syntex adjuvant formulation|Biological: MF59|Biological: Threonyl Muramyl Dipeptide|Biological: rgp120/HIV-1 SF-2|Biological: MTP-PE/MF59https://ClinicalTrials.gov/show/NCT00001042
198489198489Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)CompletedNo Results AvailableHIV Infections|PregnancyBiological: rgp120/HIV-1MNhttps://ClinicalTrials.gov/show/NCT00001041
198490198490Comparison of Ro 31-8959 Plus Zidovudine (AZT) Versus AZT Plus Zalcitabine (ddC) Versus Ro 31-8959 Plus AZT Plus ddCCompletedNo Results AvailableHIV InfectionsDrug: Saquinavir|Drug: Zidovudine|Drug: Zalcitabinehttps://ClinicalTrials.gov/show/NCT00001040
198491198491Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected PatientsCompletedNo Results AvailableMycobacterium Avium-intracellulare Infection|HIV InfectionsDrug: Ethambutol hydrochloride|Drug: Clarithromycinhttps://ClinicalTrials.gov/show/NCT00001039
198492198492A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected PatientsCompletedNo Results AvailableCytomegalovirus Infections|HIV InfectionsDrug: Valacyclovir hydrochloride|Drug: Acyclovirhttps://ClinicalTrials.gov/show/NCT00001038
198493198493A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination SchedulesCompletedNo Results AvailableHIV InfectionsBiological: gp160 Vaccine (Immuno-AG)https://ClinicalTrials.gov/show/NCT00001037
198494198494The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of InfectionCompletedNo Results AvailableHIV InfectionsDrug: Thymalfasin|Drug: Interleukin-2, Polyethylene Glycolated|Drug: Zidovudinehttps://ClinicalTrials.gov/show/NCT00001036
198495198495The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV InfectionsCompletedNo Results AvailableHIV Infections|Hepatitis CDrug: Interferon alfa-2b|Drug: Zidovudine|Drug: Zalcitabine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001035
198496198496The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIVCompletedNo Results AvailableCytomegalovirus Retinitis|HIV Infections|Gastrointestinal DiseasesDrug: Ganciclovirhttps://ClinicalTrials.gov/show/NCT00001034
198497198497The Treatment of Tuberculosis in HIV-Infected PatientsCompletedNo Results AvailableHIV Infections|TuberculosisDrug: Ethambutol hydrochloride|Drug: Isoniazid|Drug: Pyrazinamide|Drug: Pyridoxine hydrochloride|Drug: Levofloxacin|Drug: Rifampinhttps://ClinicalTrials.gov/show/NCT00001033
198498198498A Study of Dideoxycytidine Plus Zidovudine (AZT) in HIV-Infected Children Who Have Taken AZTCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Zalcitabinehttps://ClinicalTrials.gov/show/NCT00001032
198499198499A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy AdultsCompletedNo Results AvailableHIV InfectionsBiological: rgp120/HIV-1MN|Biological: rgp120/HIV-1 SF-2https://ClinicalTrials.gov/show/NCT00001031
198500198500The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected PatientsCompletedNo Results AvailableMycobacterium Avium-intracellulare Infection|HIV InfectionsDrug: Clarithromycin|Drug: Rifabutinhttps://ClinicalTrials.gov/show/NCT00001030
198501198501A Comparison of Three Treatments for Advanced HIV Disease in Patients Who Have Received Nucleoside Therapy in the PastCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Zalcitabine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001029
198502198502A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or SulfonamidesCompletedNo Results AvailablePneumonia, Pneumocystis Carinii|HIV InfectionsDrug: Pentamidine isethionate|Drug: Dapsonehttps://ClinicalTrials.gov/show/NCT00001028
198503198503A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-SulfamethoxazoleCompletedNo Results AvailablePneumonia, Pneumocystis Carinii|HIV InfectionsDrug: Pentamidine isethionatehttps://ClinicalTrials.gov/show/NCT00001027
198504198504A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive IndividualsCompletedNo Results AvailableHIV InfectionsBiological: gp160 Vaccine (Immuno-AG)|Biological: rgp120/HIV-1IIIB|Biological: rgp120/HIV-1MN|Biological: rgp120/HIV-1 SF-2|Biological: HIVAC-1ehttps://ClinicalTrials.gov/show/NCT00001026
198505198505Evaluation of Patients Who Have Not Had Success With ZidovudineCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001025
198506198506The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDSCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001024
198507198507The Safety and Effectiveness of Rifabutin, Combined With Clarithromycin or Azithromycin, in HIV-Infected PatientsCompletedNo Results AvailableMycobacterium Avium-intracellulare Infection|HIV InfectionsDrug: Clarithromycin|Drug: Azithromycin|Drug: Rifabutinhttps://ClinicalTrials.gov/show/NCT00001023
198508198508A Comparison of Zidovudine (AZT) Used Alone or in Combination With Didanosine (ddI) or Dideoxycytidine (ddC) in HIV-Infected PatientsCompletedNo Results AvailableHIV InfectionsDrug: Zidovudine|Drug: Zalcitabine|Drug: Didanosinehttps://ClinicalTrials.gov/show/NCT00001022
198509198509A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120/HIV-1 Vaccine in Healthy Adult Subjects (NOTE: Original Study Extended ONLY for Patients Previously Enrolled on VCompletedNo Results AvailableHIV InfectionsBiological: rgp120/HIV-1IIIB|Biological: rgp120/HIV-1MNhttps://ClinicalTrials.gov/show/NCT00001021
198510198510A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)CompletedNo Results AvailableHIV InfectionsBiological: rgp120/HIV-1IIIB|Biological: rgp120/HIV-1MNhttps://ClinicalTrials.gov/show/NCT00001020

* Görseller ve İçerik tekif hakkına sahip olabilir